Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.
| Revenue (Most Recent Fiscal Year) | $573.28M |
| Net Income (Most Recent Fiscal Year) | $-33.54M |
| PE Ratio (Current Year Earnings Estimate) | 14.61 |
| PE Ratio (Trailing 12 Months) | 13.88 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.02 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.85 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 6.49 |
| Pre-Tax Margin (Trailing 12 Months) | 0.85% |
| Net Margin (Trailing 12 Months) | -0.03% |
| Return on Equity (Trailing 12 Months) | 23.04% |
| Return on Assets (Trailing 12 Months) | 6.04% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.48 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.96 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 1.48 |
| Inventory Turnover (Trailing 12 Months) | 1.96 |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.28 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.21 |
| Earnings per Share (Most Recent Fiscal Year) | $0.49 |
| Diluted Earnings per Share (Trailing 12 Months) | $0.00 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 82.68M |
| Free Float | 55.40M |
| Market Capitalization | $573.79M |
| Average Volume (Last 20 Days) | 0.33M |
| Beta (Past 60 Months) | 0.84 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 33.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 62.94% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |